
Join to view full profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Leis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jose Leis is an oncologist in Scottsdale, AZ and is affiliated with Mayo Clinic Hospital. He received his medical degree from University of Arizona College of Medicine - Tucson and has been in practice 31 years. He specializes in hematologic oncology and is experienced in acute and chronic leukemias, lymphoma, myelodysplasia, myelofibrosis, and bone marrow transplantation.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1993
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1986 - 1989
University of Arizona College of MedicineClass of 1986
Certifications & Licensure
OR State Medical License 1997 - Present
AZ State Medical License 2007 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Press Ganey Top Provider Recognition Award Office of Mayo Clinic Experience, Mayo Clinic Arizona, 2020
- Top Doctors:Arizona State Castle Connolly, 2013-2020
- CMS Meaningful Use Stage 1 Certification FirstNet (Image Results), Cerner Corporation, 2014-2015, 2017
Clinical Trials
- Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Publications & Presentations
PubMed
- Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.Lauren D Pomerantz, Kari G Rabe, Paul J Hampel, Lindsey E Roeker, Rachel J Bailen
Leukemia & Lymphoma. 2026-08-01 - 1 citationsChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guide...Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, Yucai Wang, Mazie Tsang
Mayo Clinic Proceedings. 2026-07-01 - 2 citationsCentral nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience.Domitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, Lindsey E Roeker, Saad S Kenderian
Blood Cancer Journal. 2026-01-07
Journal Articles
- Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical CentreSameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology
Abstracts/Posters
- Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphoc...Jose F. Leis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...Jose F. Leis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E19...Jose F. Leis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Management of Steroid Resistant Acute and Chronic GVHD: Are We Making Progress?CIBMTR and ASBMT BMT Tandem Meeting, Salt Lake City, UT - 2/2018
- CLL: What To Do After BTK Inhibitor Therapy FailsGreat Debates & Updates in Hematologic Malignancies, New York, NY - 4/2018
- How I Treat Newly Diagnosed, Relapsed, and Transformed CLL PatientsAmerican Society of Hematology (ASH) Meeting on Hematologic Malignancies, Chicago, IL - 9/2019
Professional Memberships
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
- European Society of HematologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: